Lawrence McGee, MD
Nephrology · Spartanburg, SCNPI 1124008644
Payments from drug & device makers
Across 525 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Mallinckrodt Hospital Products Inc.$932
- Akebia Therapeutics Inc$930
- AstraZeneca$901
- Bayer$739
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 59 | $1,255 |
| Otsuka America Pharmaceutical, Inc. | 79 | $1,216 |
| Mallinckrodt Hospital Products Inc. | 29 | $932 |
| Akebia Therapeutics Inc | 38 | $930 |
| AstraZeneca | 48 | $901 |
| Bayer | 63 | $739 |
| Travere Therapeutics, Inc. | 28 | $686 |
| Vifor Pharma, Inc. | 35 | $643 |
| GSK | 22 | $579 |
| Novartis | 18 | $405 |
| OPKO Pharmaceuticals, LLC | 17 | $273 |
| Calliditas Therapeutics US Inc. | 10 | $238 |
| Nuwellis, Inc. | 3 | $220 |
| Mallinckrodt Enterprises LLC | 7 | $212 |
| Aurinia Pharma U.S., Inc. | 11 | $209 |
| Ardelyx, Inc. | 8 | $195 |
| ANI Pharmaceuticals, Inc. | 11 | $176 |
| Novo Nordisk | 6 | $137 |
| Daiichi Sankyo Inc. | 7 | $130 |
| Boehringer Ingelheim | 3 | $121 |
| Rockwell Medical, Inc. | 4 | $76 |
| Arbor Pharmaceuticals, Inc. | 4 | $74 |
| Fresenius USA Marketing, Inc. | 4 | $65 |
| Lilly USA, LLC | 2 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Scpharmaceuticals Inc. | 2 | $44 |
| Apellis Pharmaceuticals, Inc. | 1 | $30 |
| Cormedix Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
How this compares
$10,665 in reported general payments places this provider in the 80th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Spartanburg
- Muhammad EbrahimSpartanburg$146K
- Subhashini SubramaniamSpartanburg$13K
- Tanya TangSpartanburg$11K
- Matthew LambertSpartanburg$9K
- Kofi AppiahSpartanburg$7K
- Charles MurdockSpartanburg$7K
- Barry GorlitskyGreenville$3.1M
- Moustafa MoustafaOrangeburg$3M
- Amy SpragueGeorgetown$1.5M
- Pusadee SuchindaSumter$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.